Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
age, America, ARB, created, deal, delayed, delaying, director, disperse, dispersed, domestic, enhanced, flexibility, forgive, integration, issuance, mandatorily, modification, monitoring, negotiate, noncontrolling, provision, realization, redeemable, resigned, safety, South, spent, staffing, sterility, supply, SystemTM, targeted, tax, transition, uncertainty, unconsolidated
Removed:
appraiser, assisted, conducting, enrolling, forgave, identification, independent, Item, retained
Filing tables
Filing exhibits
ELGX similar filings
Filing view
External links
Exhibit 32.2
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, David M. Richards, Chief Financial Officer of Endologix, Inc. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
| (1) | the Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2003 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and | ||
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: November 7, 2003 | By: | /s/ David M. Richards | ||
| David M. Richards | ||||
| Chief Financial Officer |